We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+16.45%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$157M
AUM Growth
+$19.3M
Cap. Flow
+$6.96M
Cap. Flow %
4.45%
Top 10 Hldgs %
59.23%
Holding
147
New
34
Increased
35
Reduced
16
Closed
30

Top Buys

Rank Stock Value
1
DOYU
DouYu International Holdings
DOYU
+$3.38M
2
XLNX
Xilinx Inc
XLNX
+$3.14M
3
SOGO
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
+$3.13M
4
IPHI
INPHI CORPORATION
IPHI
+$3.03M
5
BIDU icon
Baidu
BIDU
+$2.22M

Top Sells

Rank Stock Value
1
AMTD
TD Ameritrade Holding Corp
AMTD
+$7.15M
2
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$3.49M
3
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
+$3.16M
4
WMGI
Wright Medical Group Inc
WMGI
+$2.99M
5
BABA icon
Alibaba
BABA
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 36.93%
2 Healthcare 27.25%
3 Financials 7.02%
4 Consumer Discretionary 4.71%
5 Communication Services 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRST icon
126
Primis Financial Corp
FRST
$405M
– –
-11,500
Closed -$100K
INSM icon
127
Insmed
INSM
$29B
– –
-17,635
Closed -$567K
KOD icon
128
Kodiak Sciences
KOD
$2.64B
– –
-10,097
Closed -$598K
PRTA icon
129
Prothena Corp
PRTA
$473M
– –
-44,414
Closed -$444K
QNST icon
130
QuinStreet
QNST
$1.2B
– –
-12,400
Closed -$196K
RBBN icon
131
Ribbon Communications
RBBN
$356M
– –
-19,700
Closed -$76K
RYZ
132
Ryerson Holding Corp
RYZ
$1.44B
– –
-18,100
Closed -$104K
XENE icon
133
Xenon Pharmaceuticals
XENE
$6.11B
– –
-43,517
Closed -$482K
XNCR icon
134
Xencor
XNCR
$1.64B
– –
-14,315
Closed -$555K
MTEM
135
DELISTED
Molecular Templates, Inc.
MTEM
– –
-3,158
Closed -$517K
AGTC
136
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-15,200
Closed -$74K
DRNA
137
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-24,920
Closed -$448K
FPRX
138
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-20,500
Closed -$96K
MYOK
139
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-4,780
Closed -$652K
WMGI
140
DELISTED
Wright Medical Group Inc
WMGI
– –
-97,960
Closed -$2.99M
LVGO
141
DELISTED
Livongo Health, Inc. Common Stock
LVGO
– –
-24,925
Closed -$3.49M
IMMU
142
DELISTED
Immunomedics Inc
IMMU
– –
-11,722
Closed -$997K
AMTD
143
DELISTED
TD Ameritrade Holding Corp
AMTD
– –
-182,630
Closed -$7.15M
DLPH
144
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
– –
-189,132
Closed -$3.16M
ZGNX
145
DELISTED
Zogenix, Inc.
ZGNX
– –
-19,492
Closed -$349K
LUNA
146
DELISTED
Luna Innovations Incorporated
LUNA
– –
-12,900
Closed -$77K
BDSI
147
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-22,600
Closed -$84K
2 3 4 5
6

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q4 2020 Portfolio in Review

As of Q4 2020, HighVista Strategies held 147 positions worth $157M, up 14% from $137M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

HighVista Strategies deployed $6.96M of net new capital in Q4 2020, opening 34 new positions and adding to 35 existing holdings. Its largest new stake was DouYu International Holdings: 24,960 shares worth $2.76M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 37% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alibaba, an estimated $1.25M trimmed.

  • HighVista Strategies's largest Q4 2020 buy was DouYu International Holdings: 24,960 shares worth $2.76M.
  • HighVista Strategies added most to Adaptimmune Therapeutics in Q4 2020, an estimated $564K increase.
  • HighVista Strategies's biggest Q4 2020 reduction was Alibaba, cutting an estimated $1.25M.
  • HighVista Strategies fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $7.15M.
  • HighVista Strategies's ten largest holdings make up 59% of its $157M portfolio in Q4 2020.
  • HighVista Strategies opened 34 new positions and closed 30 in Q4 2020.
  • HighVista Strategies's portfolio value rose 14% quarter-over-quarter to $157M.

Based on HighVista Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.